Modules
Silverline Diagnostic Group, Inc.
Customer 9880
- Account Classification
- Unknown
- Classification Confidence
- Medium
- Sites
- HQ | Vendor
- Assigned Reps
- Owen Whitfield
- Website
- —
- Active Opportunity Count
- 2
- Published Count
- 0
- Revenue Base
- 0
- Known GPBase
- 0
- Analyzer Platforms
- —
- Product Groups
- —
- Recommended Contact
- Leo Delgado
- Backup Contact
- Holly Merriweather | Dr. | holly.merriweather@gmail.com | (954) 258-7028
- Last Meaningful Activity
- —
- Customer Memory
- AI inference: opportunity is based on deterministic order/quote pattern and requires normal rep validation during outreach.
- Evidence References
- Candidate CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | Customer 9880 | Candidate CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | Customer 9880
Opportunities (4)
| Source Sheet | Report Run ID | Candidate ID | Opportunity ID | Opportunity Series ID | Final Disposition | Assigned Rep | Territory Rep | Source Rep | Customer | Customer ID | Site | City | State | Region | Account Classification | Classification Confidence | Analyzer Platform | Product Group | SKU | Item Description | Quote Doc No | Order Doc No | Deterministic Signal | Revenue Low | Revenue Base | Revenue High | GP Low | GP Base | GP High | Priority Score | Confidence | Open Order | Open Quote | Suppression Status | Next Best Action | Evidence Reference |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | OPP-cc5f7d563542da0d509157ae870789bcb9e5e026ffadc7ab0dd9e285848a9553 | SER-d1d41c1aa5f24257974431a9a474b2eb76a8ebf525c9c8f1834172b91419d745 | Needs Validation | **** | **** | **** | Silverline Diagnostic Group, Inc. | 9880 | HQ | Las Vegas | NV | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1038.22 versus $2321.84; trailing 180-day revenue $3360.06 versus $4993.53; 7 days beyond expected account order date. | 641.81 | 1283.62 | 1925.43 | — | — | — | 56.35 | Needs Validation | False | True | — | CONFIRM_ACCOUNT | Candidate CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | Customer 9880 |
| Account Risk | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | OPP-e352db033ac82525589dca9a4534f296794f231b94219711e86da965b5ec6822 | SER-1c8630707d43926be2757a2b8c57ba7df96248fbf52c7bc463f55e5ee7670b81 | Needs Validation | **** | **** | **** | Silverline Diagnostic Group, Inc. | 9880 | Vendor | Las Vegas | NV | Southeast | Unknown | Medium | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $951.03 versus $1862.23; trailing 180-day revenue $2813.26 versus $2847.74; 23 days beyond expected account order date. | 775.5 | 1550.99 | 2326.49 | 155.79 | 311.59 | 467.38 | 55.43 | Needs Validation | False | False | — | CONFIRM_ACCOUNT | Candidate CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | Customer 9880 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | OPP-cc5f7d563542da0d509157ae870789bcb9e5e026ffadc7ab0dd9e285848a9553 | SER-d1d41c1aa5f24257974431a9a474b2eb76a8ebf525c9c8f1834172b91419d745 | — | **** | — | — | Silverline Diagnostic Group, Inc. | 9880 | HQ | — | NV | — | — | — | — | — | — | — | — | — | Revenue Decline; 2 independent signals; trailing 90-day revenue $1038.22 versus $2321.84; trailing 180-day revenue $3360.06 versus $4993.53; 7 days beyond expected account order date. | — | 1283.62 | — | — | — | — | 56.35 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-28445b7327e55465678b3405ddb222b16090703838f66acc60183e944eb9ab52 | Customer 9880 |
| Needs Validation | 234b565c-29e5-43bb-9356-74dd911ab649 | CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | OPP-e352db033ac82525589dca9a4534f296794f231b94219711e86da965b5ec6822 | SER-1c8630707d43926be2757a2b8c57ba7df96248fbf52c7bc463f55e5ee7670b81 | — | **** | — | — | Silverline Diagnostic Group, Inc. | 9880 | Vendor | — | NV | — | — | — | — | — | — | — | — | — | Revenue Decline; 1 independent signal; trailing 90-day revenue $951.03 versus $1862.23; trailing 180-day revenue $2813.26 versus $2847.74; 23 days beyond expected account order date. | — | 1550.99 | — | — | 311.59 | — | 55.43 | Needs Validation | — | — | — | CONFIRM_ACCOUNT | Candidate CAND-78a2d57c288e544570a24a43b9d7bf821a39622680c450d9d63272868c9e47b8 | Customer 9880 |